Statin Use May Decrease Barrett's Esophagus Risk

JULY 11, 2014
Statin use may decrease the risk of Barrett’s esophagus, according to the results of a study published online on May 2, 2014, in Gastroenterology.

The case-control study compared 303 patients diagnosed with Barrett’s esophagus with a group of selective endoscopy controls and a group of primary care controls to analyze the impact of statins on the risk for the condition. To determine statin use, researchers of the study analyzed pharmacy records during a 10-year period before patients were diagnosed with Barrett’s esophagus. Patients were recruited from primary care clinics at a Veterans Affairs center and were eligible for colonoscopy screenings or had been scheduled for elective esophagogastroduodenoscopy.

Overall, 57.4% of Barrett’s esophagus patients used statins, compared with 64.9% of endoscopy controls and 71.3% of primary care controls. The results indicated that statin use was associated with a significantly lower risk for Barrett’s esophagus compared with the combined control groups. The risk was especially decreased among obese patients who used statins and for Barrett’s esophagus segments of 3 cm or more. The study did not find a significant association between Barrett’s esophagus and nonstatin lipid-lowering medications.


SHARE THIS SHARE THIS
0
 

Marijuana Ingredient Shows Promise in Seizure Reduction

While many states across our nation are engaged in political battles over the recreational use of marijuana, researchers have been busy studying the medical benefits of cannabidiol.


 

Pharmacy Times Strategic Alliance
 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.